QCI Interpret for Oncology
Benefits of integrating targeted next-generation sequencing (NGS) panels into molecular diagnostics of solid tumors
84 views
To address this challenge, a clinical research team led by Dr. Michela Bulfoni at the Istituto di Anatomia Patologica designed custom NGS panels, named “Glioma” and “Routine Diagnostics”, targeting single nucleotide variations, insertions/deletions, fusions, and copy number variations of tumor-associated essential genes.
In this webinar, attendees will:
- Understand the clinical utility of custom-designed NGS panels for accurate tumour diagnosis
- Learn about the design and application of these NGS panels
- Gain insights into the cost-effectiveness and high sensitivity of NGS panels in improving sample throughput
Category: QCI Interpret for Oncology, Sample to Insight
Related videos
QCI Interpret for Oncology
FASTQ to final report: Ultra-fast workflow for CGP
As our molecular knowledge of cancer continually evolves, a new era in cancer...
QCI Interpret for Oncology
Comprehensive Molecular Tumor Analysis with Alacris Theranostics
Precision oncology approaches have made great strides harnessing individual...
QCI Interpret for Oncology
Real-World Applications of Clinical Metagenomic Sequencing in Cancer and Infectious Disease...
Clinical metagenomic next-generation sequencing (mNGS), the comprehensive...
QCI Interpret for Oncology
Comparison of methods in routine somatic diagnostics
Dr. Mattia Schmid from UniLabs, Switzerland compares the methods of molecular...